Benchmarking Uncertainty and Improving Risk Ranking in Multi-task Bioactivity Prediction
Abstract
Multi-task bioactivity prediction transfers information across assays, but experimental prioritization also requires uncertainty estimates that identify unreliable predictions. We benchmarked prediction accuracy and uncertainty calibration for five multi-task predictors on 100 ChEMBL27 test assays and 100 CHEMBL37 assays under the random split and the clustering split. Calibration used native, Deep Ensemble and MC Dropout uncertainty; risk ranking was compared for two Gaussian process (GP) backbones. Adaptive deep kernel fitting (ADKF) achieved the best mean calibration results, while deep kernel transfer (DKT) ranked errors more effectively than ADKF with native uncertainty. We also introduce Influence Calibrated Support Reconstruction (ICSR), a risk score for kernel-based predictors. ICSR combines measured support reconstruction errors with query-specific influence and stabilizes their weighted average toward the full-support mean to adjust Gaussian process uncertainty while preserving predicted activities. With DKT and ADKF, ICSR improved all three mean risk-ranking metrics over native uncertainty and an adapted neighborhood comparator in every panel and split. ICSR achieved a mean half-query MAE reduction (R50) of 14.2-19.6%, where R50 measures the percentage decrease in mean absolute error (MAE) after retaining the lowest-risk half of the queries. A retrospectively selected SARS-CoV-2 main protease case further illustrated its use for selecting more reliable predictions. The benchmark supports joint assessment of calibration and error ranking, while ICSR improves selective use of kernel-based bioactivity predictions.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Systematic Benchmarking of Kinase Bioactivity Models Across Splitting Strategies and Protein Representations
Joshua M. Abbott·bioRxiv·Apr 22, 2026
- Leveraging multiple data types for improved compound-kinase bioactivity prediction
Ryan Theisen, Tianduanyi Wang, … Anna Cichońska·Nature CommunicationsPeer-reviewed·Aug 31, 2024
- When Does Active Learning Improve ADMET Prediction? A Multi-Endpoint Benchmark
Viktor Najdovski, Jana Hristova, … Ilinka Ivanoska·bioRxiv·Oct 30, 2026
- Learning with uncertainty for biological discovery and design
Brian Hie, Bryan D. Bryson, Bonnie Berger·Cell SystemsPeer-reviewed·Oct 15, 2020
- Step Forward Cross Validation for Bioactivity Prediction: Out of Distribution Validation in Drug Discovery
Udit Surya Saha, Michele Vendruscolo, … Srijit Seal·bioRxiv·Jul 2, 2024
- All-Assay-Max2 pQSAR: Activity predictions as accurate as 4-concentration IC50s for 8,558 Novartis assays
Éric Martin, Valery R. Polyakov, … Xin Liu·Journal of Chemical Information and ModelingPeer-reviewed·Sep 13, 2019